DarioHealth Corp. logo

DarioHealth Corp. (DRIO)

Market Closed
12 Jun, 20:00
NASDAQ (CM) NASDAQ (CM)
$
7. 06
-0.14
-1.9444%
Pre Market
$
7. 30
+0.24 +3.3994%
51.63M Market Cap
- P/E Ratio
- Div Yield
4,769 Volume
-2.02 Eps
$ 7.2
Previous Close
Investors:
Analysts:
Add Transaction
Day Range
7.06 7.3
Year Range
5.93 17.74
Want to track DRIO and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

DRIO closed Friday lower at $7.06, a decrease of -1.9444% from Thursday's close, completing a monthly decrease of -2.6207% or -$0.19. Over the past 12 months, DRIO stock lost -40.1695%.
DRIO is not paying dividends to its shareholders.
The last earnings report, released on May 12, 2026, exceeded the consensus estimates by 0%. On average, the company has fell short of earnings expectations by -0.1525%, based on the last three reports.
DarioHealth Corp. has completed 4 stock splits, with the recent split occurring on Aug 28, 2025.
The company's stock is traded on one exchange.

DRIO Chart

People also search for

Franklin Pennsylvania Municipal Income ETF
$ 8.7
-0.1722%
Repay Holdings Corporation
$ 3.37
-1.462%
AerSale Corporation
$ 6.27
+0.4808%
WXM
WF International Ltd
$ 4.61
+2.2173%
NEO
NeoGenomics Inc.
$ 11.15
-2.7899%
DarioHealth Corp. (DRIO) Q1 2026 Earnings Call Transcript

DarioHealth Corp. (DRIO) Q1 2026 Earnings Call Transcript

DarioHealth Corp. (DRIO) Q1 2026 Earnings Call Transcript

Seekingalpha | 1 month ago
DarioHealth Q1 Earnings Call Highlights

DarioHealth Q1 Earnings Call Highlights

DarioHealth NASDAQ: DRIO reported sequential revenue growth for the second straight quarter while outlining plans to expand its digital health platform further into care delivery, management said on the company's first-quarter 2026 earnings call Wednesday.

Marketbeat | 1 month ago
DarioHealth Corp. (DRIO) Reports Q1 Loss, Beats Revenue Estimates

DarioHealth Corp. (DRIO) Reports Q1 Loss, Beats Revenue Estimates

DarioHealth Corp. (DRIO) came out with a quarterly loss of $0.81 per share versus the Zacks Consensus Estimate of a loss of $0.71. This compares to a loss of $1.2 per share a year ago.

Zacks | 1 month ago

DarioHealth Corp. Investors

Name Quantity Cost Value Profit ($) Gain (%)
HFT
Hui Fai Tam Caitong International Asset Management Co. Ltd.
1 $8 $7.06 -$0.94 -11.75%
Todd A. Rustman
Todd A. Rustman Clarity Capital Partners LLC
1,412.5 $43,222.5 $9,972.25 -$33,250.25 -76.93%

DarioHealth Corp. Analysts

Name Quantity Cost Value Profit ($) Gain (%)
DG
David Grossman Stifel
1,219.18 $9,656.42 $8,607.38 -$1,049.04 -10.86%

DarioHealth Corp. (DRIO) FAQ

What is the stock price today?

The current price is $7.06.

On which exchange is it traded?

DarioHealth Corp. is listed on NASDAQ (CM).

What is its stock symbol?

The ticker symbol is DRIO.

Does it pay dividends? What is the current yield?

It does not pay dividends to its shareholders.

What is its market cap?

As of today, the market cap is 51.63M.

Has DarioHealth Corp. ever had a stock split?

DarioHealth Corp. had 4 splits and the recent split was on Aug 28, 2025.

DarioHealth Corp. Profile

Professional Services Industry
Industrials Sector
Erez Raphael CEO
NASDAQ (CM) Exchange
23725P308 CUSIP
US Country
196 Employees
- Last Dividend
6 Oct 2014 Last Split
6 Oct 2014 IPO Date

Overview

DarioHealth Corp. is a forefront digital health company actively engaged in the development and distribution of a proprietary digital therapeutics platform and suite of solutions specifically designed to offer personalized and dynamic interventions. These interventions are powered by advanced data analytics and one-on-one coaching, targeting a variety of chronic conditions including diabetes, hypertension, weight management, musculoskeletal pain, and behavioral health. Initially founded as LabStyle Innovations Corp., the company underwent a rebranding to DarioHealth Corp. in July 2016. Headquartered in New York, New York, it extends its services across the United States, Canada, the European Union, Australia, and New Zealand, providing cutting-edge digital health solutions since its incorporation in 2011.

Products and Services

  • Dario Evolve - A comprehensive metabolic health solution designed to tackle conditions such as diabetes, pre-diabetes, hypertension, and issues related to weight management. Dario Evolve stands out for its personalized approach to enhancing metabolic health.
  • Dario Move - Specifically formulated to address common musculoskeletal conditions, Dario Move offers users targeted interventions that aim to alleviate conditions related to musculoskeletal pain, promoting overall physical well-being.
  • Dario Elevate - A behavioral health solution that ensures optimized access to evidence-based care, Dario Elevate focuses on addressing the intricacies of behavioral health with an aim to improve mental wellbeing through structured and effective interventions.
  • Dario One - Represents the full suite of chronic condition management solutions offered by DarioHealth. Dario One integrates various health management tools and services into a cohesive package, providing users with a comprehensive approach to managing their health conditions effectively.
  • Dario Blood Glucose Monitoring Systems - An essential tool for individuals managing diabetes, this system offers accurate blood glucose measurements, facilitating the daily management of diabetes through precise monitoring and feedback.

In addition to these innovative digital solutions, DarioHealth Corp. supplies native devices integral to the management and monitoring of chronic conditions. These include a glucose meter, blood pressure cuff, digital scale, and a biofeedback sensor device. Complementing its range of products, DarioHealth also provides live coaching services, offering personalized guidance and support to its users, thereby enhancing the effectiveness of its digital health solutions.

Contact Information

Address: 18 West 18th Street
Phone: 833 914 3796